[Optimizing antihypertensive therapy. In 5 years 35,000 strokes are preventable].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000453:epidemiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003430:Cross-Sectional Studies; D005060:Europe; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy; D019808:Losartan / Q000627:therapeutic use*; D008875:Middle Aged
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001262:Atenolol; D019808:Losartan